Reuters logo
BRIEF-Novartis says book value of current Alcon division is around $21 bln
May 31, 2017 / 1:23 PM / 4 months ago

BRIEF-Novartis says book value of current Alcon division is around $21 bln

May 31 (Reuters) - Novartis

* Novartis CEO Joe Jimenez says there has been no change to plans for the Swiss drugmaker’s Roche stake

* Novartis is open for opportunity to exit Roche stake but is “in no hurry to sell”

* Novartis CEO says “we don’t need a big deal” and that the company sticking to strategy of bolt-on acquisitions

* Jimenez says disbanding stand-alone cell and gene therapy unit in 2016 reduced costs, increased speed of decisionmaking on CAR-T oncology program

* Novartis says book value of current Alcon division is around $21 billion Source text for Eikon: Further company coverage: (Reporting by John Miller)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below